Amphotericin B in lung transplant recipients. - Wikidata - wikimedia - TriplyDB

Amphotericin B in lung transplant recipients.

Amphotericin B in lung transplant recipients.

http://www.wikidata.org/entity/Q43869905

about

Novel modes of antifungal drug administration.Liposomal amphotericin B: clinical experience and perspectives.Variation in antifungal prophylaxis strategies in lung transplantation.

P2860

Q35842520-5D1D4ED2-9E66-4C36-9695-DD6E5B7DC857 Q36140647-5DD658DB-1C47-4C3F-8386-E8917A61635A Q40268302-BBE8AFFA-231A-4EC9-A9B6-68E60887601E

P2860

Amphotericin B in lung transplant recipients.

http://www.wikidata.org/entity/Q43869905

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Amphotericin B in lung transplant recipients.

@en

Amphotericin B in lung transplant recipients.

@nl

type

label

Amphotericin B in lung transplant recipients.

@en

Amphotericin B in lung transplant recipients.

@nl

prefLabel

Amphotericin B in lung transplant recipients.

@en

Amphotericin B in lung transplant recipients.

@nl

P1433

Q43869905-150D3DA4-7300-4A75-8B12-BE37ADFEB9F6

P1476

Q43869905-DE49AF88-8338-484D-AF52-A697B5411AB9

P2093

Q43869905-8DFDAA88-0D81-43FA-BAEF-3639DD3AA416

P2860

Q43869905-1964BAEB-281D-4366-9C4D-D31D8CD98401

Q43869905-2FFF9B28-DB7D-4137-A033-B058F3CFC3A5

Q43869905-9BE43D6A-6546-4095-880C-254281FCFE21

Q43869905-DCA2AA06-489D-47FE-9787-50897D41D18E

Q43869905-EB7063EB-A4D0-4468-8B9F-982239DBD413

Q43869905-F28E6314-4677-437C-9EEB-EE876AAB6558

Q43869905-FE50DE92-7542-49EE-80B7-CBE3FFA96A8D

P304

Q43869905-9891AFF0-EECA-46BB-99B9-484CB0246DB0

P31

Q43869905-3B2ACC88-6E4C-43AC-8166-C5397AFFCE0A

P356

Q43869905-3FE35A70-D987-4A54-A9A2-C4E1B047D1E0

P407

Q43869905-D57A071E-5ABC-4F99-963A-15328E2F69AD

P433

Q43869905-E435BA14-EA7C-44B1-9BDF-D0F291F4306C

P478

Q43869905-5E02D80D-06A5-48AF-B9B8-C7190B52EBED

P577

Q43869905-8840A3FE-A5CA-461D-A9F1-FF2893837234

P698

Q43869905-681B8F84-2C2A-41E9-B4B1-D1F92133058C

P921

Q43869905-D04797D8-2FFA-4CEE-9323-35455D71C435

P356

P1433

Annals of Pharmacotherapy

P1476

Amphotericin B in lung transplant recipients.

@en

P2093

Michael E Klepser

http://www.w3.org/2001/XMLSchema#string

P2860

Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group

Therapeutic outcome in invasive aspergillosis.

Aerosol amphotericin B for prevention of invasive pulmonary aspergillosis.

Amphotericin B disposition after aerosol inhalation in lung transplant recipients.

Antifungal prophylaxis during the early postoperative period of lung transplantation. Valencia Lung Transplant Group.

In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi.

A comparative study of the in vitro susceptibilities of clinical and laboratory-selected resistant isolates of Aspergillus spp. to amphotericin B, itraconazole, voriconazole and posaconazole (SCH 56592).

P304

167-169

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.1A360

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11816247

http://www.w3.org/2001/XMLSchema#string

P921

lung transplant